Product Benefits

• Convenient Dual Action: Combines 30% rapid/short-acting insulin and 70% intermediate-acting (NPH) insulin in one vial, significantly simplifying the daily injection routine.

• Biphasic Control: Offers a quick onset to manage post-meal blood sugar surges and a sustained duration to provide reliable basal control between meals and overnight.

• Vial Format Flexibility: Provided in a standard vial for use with insulin syringes, allowing for high flexibility in dosing and drawing up specific or fractional doses.

• Predictable Dosing: The fixed 30/70 ratio ensures a consistent and reliable pharmacological profile, aiding in predictable and effective blood sugar management.

• Effective Glucose Management: A standard and trusted therapeutic option for individuals needing both mealtime and basal insulin coverage.

• Improved Adherence: Simplifies the injection process, which can lead to better patient compliance and consistency in following the prescribed diabetes treatment plan.

• Standard Concentration: Utilizes the globally standard 100 IU/ml concentration, ensuring ease of calculation and compatibility with standard insulin syringes.